Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filing Details

Document Details

Form
Filing Date
Jun 21, 2018
Document Date
Jun 21, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
electroCore
Issuer
ElectroCore, LL
Filer
Amato Francis R.